Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Hólmfríður Helgadóttir, Sigrún H. Lund, Sveinbjörn Gizurarson, Helge Waldum & Einar S. Björnsson. (2021) Pharmacokinetics of single and repeated oral doses of esomeprazole and gastrin elevation in healthy males and females. Scandinavian Journal of Gastroenterology 56:2, pages 128-136.
Read now
Read now
David Peura, Anne Le Moigne, Charles Pollack, Peter Nagy & Tore Lind. (2016) A 14-day regimen of esomeprazole 20 mg/day for frequent heartburn: durability of effects, symptomatic rebound, and treatment satisfaction. Postgraduate Medicine 128:6, pages 577-583.
Read now
Read now
Jens F. Rehfeld. (2015) Gastrointestinal hormone research – with a Scandinavian annotation. Scandinavian Journal of Gastroenterology 50:6, pages 668-679.
Read now
Read now
Anil Pareek & Nitin Chandurkar. (2013) Comparison of gastrointestinal safety and tolerability of aceclofenac with diclofenac: a multicenter, randomized, double-blind study in patients with knee osteoarthritis. Current Medical Research and Opinion 29:7, pages 849-859.
Read now
Read now
Anders Bergh Lødrup, Christina Reimer & Peter Bytzer. (2013) Systematic review: symptoms of rebound acid hypersecretion following proton pump inhibitor treatment. Scandinavian Journal of Gastroenterology 48:5, pages 515-522.
Read now
Read now
Constantin S. Jianu, Reidar Fossmark, Unni Syversen, Øyvind Hauso, Vidar Fykse & Helge L. Waldum. (2011) Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids. Scandinavian Journal of Gastroenterology 46:4, pages 456-463.
Read now
Read now
Paul Juul-Hansen & Andreas Rydning. (2011) Clinical and pathophysiological consequences of on-demand treatment with PPI in endoscopy-negative reflux disease. Is rebound hypersecretion of acid a problem?. Scandinavian Journal of Gastroenterology 46:4, pages 398-405.
Read now
Read now
Gabriele Bianchi Porro. (2010) EDITORIAL. Scandinavian Journal of Gastroenterology 45:4, pages 387-388.
Read now
Read now
Articles from other publishers (41)
L. Veremme, A. Baudouin, A. Janoly-Dumenil & B. Charpiat. (2023) Thésaurus d’interventions pharmaceutiques associées aux prescriptions injustifiées d’inhibiteurs de la pompe à protons. Annales Pharmaceutiques Françaises 81:3, pages 552-567.
Crossref
Crossref
Giammarco Baiardi, Giulia Calvini, Serena Panarello, Chiara Fioravanti, Manuela Stella, Antonietta Martelli, Giancarlo Antonucci & Francesca Mattioli. (2023) Prescriptive Appropriateness: Inhospital Adherence to Proton Pump Inhibitors Deprescription Flow Chart. Pharmaceuticals 16:5, pages 635.
Crossref
Crossref
Thane Blinman & Dennis Hiller. (2023) Troubleshooting the pediatric gastrostomy. Nutrition in Clinical Practice 38:2, pages 240-256.
Crossref
Crossref
Malte H. Wehmeyer, Thomas Horvatits, Anika Buchholz, Linda Krause, Sarah Walter, Antonia Zapf, Ansgar W. Lohse & Johannes Kluwe. (2022) Stop of proton-pump inhibitor treatment in patients with liver cirrhosis (STOPPIT): study protocol for a prospective, multicentre, controlled, randomized, double-blind trial. Trials 23:1.
Crossref
Crossref
Sanat Kumar Dash, Sasmita Kumari Acharjya, Atyurmila Chakraborty, Mitali Sahoo, Satyanarayan Tripathy, Bimala Tripathy & Ramanath Deo. (2022) Application of Analytical Tools and Techniques for Estimation of a Proton Pump Inhibitor (Esomeprazole Magnesium Trihydrate): A Comprehensive Review. Current Pharmaceutical Analysis 18:7, pages 677-693.
Crossref
Crossref
Decio CHINZON, Gerson DOMINGUES, Nivia TOSETTO & Marcos PERROTTI. (2022) SAFETY OF LONG-TERM PROTON PUMP INHIBITORS: FACTS AND MYTHS. Arquivos de Gastroenterologia 59:2, pages 219-225.
Crossref
Crossref
Mubashira K Sarnaik, Srimy Modi, Yasaswi Pisipati, Sarayoo Vaidya, Naqvi Syed Gaggatur, Aliya H Sange, Natasha Srinivas & Ibrahim Sange. (2021) Proton Pump Inhibitors: Exploring Cardiovascular Complications and Prescription Protocol. Cureus.
Crossref
Crossref
Valeria Atenea Costa, Oscar Mariano Pinto Saavedra, Albis Cecilia Hani Amador, Ana María Leguízamo Naranjo & Andrés Felipe Ardila Hani. (2021) Actualización en la interpretación de la medición del pH e impedanciometría. Revista colombiana de Gastroenterología 36:1, pages 73-80.
Crossref
Crossref
Hólmfridur Helgadóttir, Sigrún H. Lund, Sveinbjörn Gizurarson, David C. Metz & Einar S. Björnsson. (2020) Predictors of Gastrin Elevation Following Proton Pump Inhibitor Therapy. Journal of Clinical Gastroenterology 54:3, pages 227-234.
Crossref
Crossref
Jinkun Guo & Zhongyin Zhou. (2020) Proton pump inhibitors and stomach neoplasm. Oncology and Translational Medicine 6:1, pages 26-29.
Crossref
Crossref
Helgadottir & Bjornsson. (2019) Problems Associated with Deprescribing of Proton Pump Inhibitors. International Journal of Molecular Sciences 20:21, pages 5469.
Crossref
Crossref
Lingaku Lee, Irene Ramos-Alvarez, Tetsuhide Ito & Robert T. Jensen. (2019) Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome. International Journal of Molecular Sciences 20:20, pages 5128.
Crossref
Crossref
Elizabeth Golly, Adesola Odunayo, Maggie Daves, Julie Vose, Josh Price, Silke Hecht, Joerg M. Steiner, Shanna Hillsman & M. Katherine Tolbert. (2019) The frequency of oral famotidine administration influences its effect on gastric pH in cats over time. Journal of Veterinary Internal Medicine 33:2, pages 544-550.
Crossref
Crossref
Oliver Reichel. 2019. Pädiatrische HNO-Heilkunde. Pädiatrische HNO-Heilkunde
353
363
.
Peter Fentz Haastrup, Wade Thompson, Jens Søndergaard & Dorte Ejg Jarbøl. (2018) Side Effects of Long-Term Proton Pump Inhibitor Use: A Review. Basic & Clinical Pharmacology & Toxicology 123:2, pages 114-121.
Crossref
Crossref
Michaël Rochoy, Sébastien Dubois, Raymond Glantenet, Sophie Gautier & Marc Lambert. (2018) Le rebond d’acidité gastrique après arrêt d’un inhibiteur de la pompe à protons : revue narrative de littérature. Therapies 73:3, pages 237-246.
Crossref
Crossref
Óskar Ö. Hálfdánarson, Anton Pottegård, Einar S. Björnsson, Sigrún H. Lund, Margret H. Ogmundsdottir, Eiríkur Steingrímsson, Helga M. Ogmundsdottir & Helga Zoega. (2018) Proton-pump inhibitors among adults: a nationwide drug-utilization study. Therapeutic Advances in Gastroenterology 11, pages 175628481877794.
Crossref
Crossref
Hólmfridur Helgadóttir, David C. Metz, Sigrún H. Lund, Sveinbjorn Gizurarson, Elin I. Jacobsen, Gudrún A. Asgeirsdóttir, Yrsa Yngadóttir & Einar S. Björnsson. (2017) Study of Gender Differences in Proton Pump Inhibitor Dose Requirements for GERD. Journal of Clinical Gastroenterology 51:6, pages 486-493.
Crossref
Crossref
Arjun Poudel, Anna Ballokova, Ruth E Hubbard, Leonard C Gray, Charles A Mitchell, Lisa M Nissen & Ian A Scott. (2015) Algorithm of medication review in frail older people: Focus on minimizing the use of high‐risk medications. Geriatrics & Gerontology International 16:9, pages 1002-1013.
Crossref
Crossref
Roman A. Sukhovershin & John P. Cooke. (2016) How May Proton Pump Inhibitors Impair Cardiovascular Health?. American Journal of Cardiovascular Drugs 16:3, pages 153-161.
Crossref
Crossref
E. Gould, C. Clements, A. Reed, L. Giori, J.M. Steiner, J.A. Lidbury, J.S. Suchodolski, M. Brand, T. Moyers, L. Emery & M.K. Tolbert. (2016) A Prospective, Placebo‐Controlled Pilot Evaluation of the Effect of Omeprazole on Serum Calcium, Magnesium, Cobalamin, Gastrin Concentrations, and Bone in Cats. Journal of Veterinary Internal Medicine 30:3, pages 779-786.
Crossref
Crossref
Joseph R. Pisegna & Deepinder Goyal. 2015. Yamada' s Textbook of Gastroenterology. Yamada' s Textbook of Gastroenterology
3058
3070
.
Emily Reeve, Jane M. Andrews, Michael D. Wiese, Ivanka Hendrix, Michael S. Roberts & Sepehr Shakib. (2014) Feasibility of a Patient-Centered Deprescribing Process to Reduce Inappropriate Use of Proton Pump Inhibitors. Annals of Pharmacotherapy 49:1, pages 29-38.
Crossref
Crossref
Thane Blinman. 2015. Disorders of the Neonatal Airway. Disorders of the Neonatal Airway
281
294
.
Jasmohan S. BajajI. Jane CoxNaga S. BetrapallyDouglas M. HeumanMitchell L. SchubertMaiyuran Ratneswaran, Phillip B. Hylemon, Melanie B. WhiteKalyani DaitaNicole A. NobleMasoumeh SikaroodiRoger WilliamsMary M. E. Crossey, Simon D. Taylor-Robinson & Patrick M. Gillevet. (2014) Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function. American Journal of Physiology-Gastrointestinal and Liver Physiology 307:10, pages G951-G957.
Crossref
Crossref
Mitchell L. Schubert. 2014. Gastrointestinal Anatomy and Physiology. Gastrointestinal Anatomy and Physiology
58
77
.
H. L. Waldum, Ø. Hauso & R. Fossmark. (2014) The regulation of gastric acid secretion - clinical perspectives. Acta Physiologica 210:2, pages 239-256.
Crossref
Crossref
Hólmfridur Helgadóttir, David C. Metz, Yu-Xiao Yang, Andrew D. Rhim & Einar S. Björnsson. (2014) The effects of long-term therapy with proton pump inhibitors on meal stimulated gastrin. Digestive and Liver Disease 46:2, pages 125-130.
Crossref
Crossref
Marcus Zulian Teixeira. (2013) Efeito rebote dos fármacos modernos: evento adverso grave desconhecido pelos profissionais da saúde. Revista da Associação Médica Brasileira 59:6, pages 629-638.
Crossref
Crossref
Daniel Gelfond, Changxing Ma, Jack Semler & Drucy Borowitz. (2012) Intestinal pH and Gastrointestinal Transit Profiles in Cystic Fibrosis Patients Measured by Wireless Motility Capsule. Digestive Diseases and Sciences 58:8, pages 2275-2281.
Crossref
Crossref
Jonathan C. King & O. Joe Hines. 2013. Shackelford's Surgery of the Alimentary Tract. Shackelford's Surgery of the Alimentary Tract
638
647
.
Saman Chubineh & John Birk. (2012) Proton Pump Inhibitors. Southern Medical Journal 105:11, pages 613-618.
Crossref
Crossref
Neena S. Abraham. (2012) Proton pump inhibitors. Current Opinion in Gastroenterology 28:6, pages 615-620.
Crossref
Crossref
David C Metz, Betsy L Pilmer, Cong Han & Claudia M Perez. (2011) Withdrawing PPI Therapy After Healing Esophagitis Does Not Worsen Symptoms or Cause Persistent Hypergastrinemia: Analysis of Dexlansoprazole MR Clinical Trial Data. American Journal of Gastroenterology 106:11, pages 1953-1960.
Crossref
Crossref
Yaron Niv. (2011) Gradual cessation of proton pump inhibitor (PPI) treatment may prevent rebound acid secretion, measured by the alkaline tide method, in dyspepsia and reflux patients. Medical Hypotheses 77:3, pages 451-452.
Crossref
Crossref
Marcus Zulian Teixeira. (2011) Rebound acid hypersecretion after withdrawal of gastric acid suppressing drugs: new evidence of similitude. Homeopathy 100:3, pages 148-156.
Crossref
Crossref
Kathryn S. Rice, Graeme Dickson, Mark Lane, Jackie Crawford, Seo-Kyung Chung, Mark I. Rees, Andrew N. Shelling, Donald R. Love & Jonathan R. Skinner. (2011) Elevated serum gastrin levels in Jervell and Lange-Nielsen syndrome: A marker of severe KCNQ1 dysfunction?. Heart Rhythm 8:4, pages 551-554.
Crossref
Crossref
Edward Sheen & George Triadafilopoulos. (2011) Adverse Effects of Long-Term Proton Pump Inhibitor Therapy. Digestive Diseases and Sciences 56:4, pages 931-950.
Crossref
Crossref
Jeremiah V. Ojeaburu, Tetsuhide Ito, Pellegrino Crafa, Cesare Bordi & Robert T. Jensen. (2010) Mechanism of Acid Hypersecretion Post Curative Gastrinoma Resection. Digestive Diseases and Sciences 56:1, pages 139-154.
Crossref
Crossref
Mitchell L Schubert. (2010) Gastric secretion. Current Opinion in Gastroenterology 26:6, pages 598-603.
Crossref
Crossref
Denis M McCarthy. (2010) Adverse effects of proton pump inhibitor drugs: clues and conclusions. Current Opinion in Gastroenterology 26:6, pages 624-631.
Crossref
Crossref